CNS Pharmaceuticals, Inc. (CNSP) › Shareholders' EquityCNS Pharmaceuticals, Inc. (CNSP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$58.5K2018: -$549.3K2019: $7.60M2020: $13.95M2021: $6.16M2022: $8.13M2023: -$4.43M2024: $6.18M2025: $4.52M$4.52M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.52M-26.8%2024$6.18M+239.4%2023-$4.43M-154.5%2022$8.13M+32.0%2021$6.16M-55.8%2020$13.95M+83.5%2019$7.60M+1483.8%2018-$549.3K-838.5%2017-$58.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share